Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy.
Yano M, Sharpe C, Lance JR, Ravikrishnan J, Zapolnik K, Mo X, Woyach JA, Sampath D, Kittai AS, Vasu S, Bhat S, Rogers KA, Lee DA, Muthusamy N, Byrd JC.
Yano M, et al. Among authors: byrd jc.
Blood Adv. 2022 Oct 25;6(20):5641-5654. doi: 10.1182/bloodadvances.2021005883.
Blood Adv. 2022.
PMID: 35486482
Free PMC article.